Literature DB >> 19358181

Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.

F Parente1, B Marino, N DeVecchi, R Moretti, G Ucci, P Tricomi, A Armellino, L Redaelli, S Bargiggia, E Cristofori, E Masala, F Tortorella, A Gattinoni, F Odinolfi, M E Pirola.   

Abstract

BACKGROUND: The results of a pilot colorectal cancer screening programme by biennial immunochemical faecal occult blood test (FOBT) are reported.
METHODS: All residents aged between 50 and 69 years in the Italian province of Lecco were invited to have a FOBT. Those with a positive result were offered colonoscopy. FOBT uptake and compliance with colonoscopy were assessed. Detection rate and positive predictive value (PPV) for cancer and adenoma were calculated. Tumour stages were compared between screen-detected cancers and other colorectal cancers diagnosed within the target age group.
RESULTS: Some 38,693 (49.6 per cent) of 78,083 individuals had a FOBT and 2392 (6.2 per cent) had a positive result. Colorectal cancer was diagnosed in 4.6 per cent and advanced adenoma in 32.7 per cent. PPVs were 4.0 per cent for cancer, 28.1 per cent for advanced adenoma and 36.6 per cent for any adenoma. There was a significant difference in incidence of stage III/IV disease between screened and non-screened cohorts. Compliance for colonoscopy was 92.0 per cent. Major determinants of compliance were age less than 59 years, female sex, high education level and non-manual work.
CONCLUSION: These results justify extension of colorectal cancer screening to other regions of Italy. 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 19358181     DOI: 10.1002/bjs.6568

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  14 in total

1.  Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT.

Authors:  Cristina Zaccaro; Ilaria Maria Saracino; Giulia Fiorini; Natale Figura; John Holton; Valentina Castelli; Valeria Pesci; Luigi Gatta; Dino Vaira
Journal:  Intern Emerg Med       Date:  2017-02-02       Impact factor: 3.397

Review 2.  Mechanism of action and toxicities of purgatives used for colonoscopy preparation.

Authors:  Margaret Adamcewicz; Dilip Bearelly; Gail Porat; Frank K Friedenberg
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-01       Impact factor: 4.481

3.  Socioeconomic position and participation in colorectal cancer screening.

Authors:  B L Frederiksen; T Jørgensen; K Brasso; I Holten; M Osler
Journal:  Br J Cancer       Date:  2010-10-19       Impact factor: 7.640

4.  An innovative strategy to reach the underserved for colorectal cancer screening.

Authors:  Katherine Josa Briant; Noah Espinoza; Avigail Galvan; Elizabeth Carosso; Nathan Marchello; Sandra Linde; Wade Copeland; Beti Thompson
Journal:  J Cancer Educ       Date:  2015-06       Impact factor: 2.037

5.  Association of employment and company size with lung cancer screening participation among Japanese based on the socioeconomic conditions using the Comprehensive Survey of Living Conditions.

Authors:  Mitsuya Maeda; Ronald Filomeno; Yumi Kawata; Tomoyo Sato; Koutatsu Maruyama; Motoki Endo; Hiroo Wada; Ai Ikeda; Takeshi Tanigawa
Journal:  Int J Clin Oncol       Date:  2020-03-18       Impact factor: 3.402

6.  Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.

Authors:  Reinier G S Meester; Ann G Zauber; Chyke A Doubeni; Christopher D Jensen; Virginia P Quinn; Mark Helfand; Jason A Dominitz; Theodore R Levin; Douglas A Corley; Iris Lansdorp-Vogelaar
Journal:  Clin Gastroenterol Hepatol       Date:  2016-05-19       Impact factor: 11.382

7.  Anatomic distribution of cancers and colorectal adenomas according to age and sex and relationship between proximal and distal neoplasms in an i-FOBT-positive average-risk Italian screening cohort.

Authors:  F Parente; S Bargiggia; C Boemo; C Vailati; E Bonoldi; A Ardizzoia; A Ilardo; F Tortorella; S Gallus
Journal:  Int J Colorectal Dis       Date:  2013-08-24       Impact factor: 2.571

8.  Circulating tumour markers can define patients with normal colons, benign polyps, and cancers.

Authors:  R Mead; M Duku; P Bhandari; I A Cree
Journal:  Br J Cancer       Date:  2011-06-28       Impact factor: 7.640

9.  Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme.

Authors:  S Morris; G Baio; E Kendall; C von Wagner; J Wardle; W Atkin; S P Halloran; G Handley; R F Logan; A Obichere; S Rainbow; S Smith; J Snowball; R Raine
Journal:  Br J Cancer       Date:  2012-08-02       Impact factor: 7.640

Review 10.  Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials.

Authors:  B Joseph Elmunzer; Rodney A Hayward; Philip S Schoenfeld; Sameer D Saini; Amar Deshpande; Akbar K Waljee
Journal:  PLoS Med       Date:  2012-12-04       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.